Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 3c, Slight Miss on Revenues; Updates FY17 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 3c, Slight Miss on Revenues; Updates FY17 Outlook

Jazz Pharmaceuticals (JAZZ) PT Lowered to $174 at Deutsche Bank; 'Decent Q, 2017 shaping up nicely'

May 10, 2017 9:06 AM EDT

Deutsche Bank lowered its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $174.00 (from $176.00) while maintaining a Buy rating.

... More